Publications

  • News for the Week of September 29, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Update on COVID-19 Testing in Pharmacies
    • Updated: COVID-19 Provincial Testing Guidance
    • Universal Influenza Immunization Program (UIIP) Updates
    • NIHB Program: Availability of US Labelled SUBLOCADE Product on Canadian Market Due to Shortage
    • Red Cross Recertification Extension

    • Secure Your Stock of Hand Sanitizer
    • Dell Canada Special Offer

    • *FREE* Training for Asymptomatic COVID-19 Testing in Pharmacy
    • *FREE* Protecting Your Patients: Operationalizing Adult Immunizations
    • Injections and Immunizations Certificate Program

    • Deadline to Get your 15% Reduced Driving Refund Extended
    • Protect your Family with OPA Group Health Plan

    • Week of September 21 – DSU Weekly Update to Provinces and Territories

    • DDD Notice No. 20148 Posted September 24, 2020: ODB Formulary Edition No. 43, Summary of Changes – September 30, 2020
    • DDD Notice No. 20147 Posted September 24, 2020 Prescription Forgery Alert
    • DDD Notice No. 20146 Posted September 23, 2020 Prescription Forgery Alert

    • Health Product InfoWatch, September 2020
    • All Strengths of Mar-Diltiazem CD, a Drug Used to Treat Angina and Hypertension, Have Been Recalled Because of Dosing Concerns
    • Recall of Certain Hand Sanitizers That May Pose Health Risks

  • News for the Week of September 22, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Ontario Pharmacists Pleased to Play a Role in Ontario Government’s Fall Preparedness Plan
    • COVID-19 Testing and Regulatory Changes Update
    • M Postal Code Flu Vaccine Distribution
    • Updated: OPA’s Universal Influenza Immunization Program (UIIP) 2020-21 Frequently Asked Questions
    • Community Practice Environment Initiative - Registrant Survey

    • Ask the Customer Experience and Administration Team
    • The Ontario Pharmacist (TOP) Magazine Available Now!
    • Canadian Red Cross Reminder: Act Quickly! Register for Certification Courses Now

    • A Practical Approach to Laboratory Abnormalities
    • Managing Your Pharmacy: The Business Essentials
    • OPA’s Webinar Series: The Right Dose - Protecting Your Patients: Operationalizing Adult Immunizations

    • OPA Secure Health Plan Rate Changes
    • Student Travel Insurance Notice

    • Health Canada Reviews Safety of Drug Fibristal Again Following New Case of Liver Injury

  • News for the Week of September 15, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Is COVID-19 Testing Coming to Pharmacies?
    • CPhA News Release: Canadians Urge Expanding COVID-19 Asymptomatic Testing Across Canada
    • ICYMI: Important Reminder Regarding Age-eligibilities for Pharmacist-administered Flu Vaccinations Under the UIIP 2020-2021
    • Suggested Best Practices for Community Pharmacy Providing Influenza Immunizations During the COVID-19 Pandemic
    • COVID-19 Resources and Tools
    • ICYMI: Students of OPA – Share Your Voice and Shape the Future of the Profession
    • Pharmacists' Matters: COVID-19 Testing in Pharmacy - The Alberta Story

    • Ask the Practice Support Network

    • How Can Pharmacists Optimize the Care of Patients With Heart Failure?
    • Pharmacist Health Coaching – Cardiovascular Program Training Course
    • Digital Disruption and Impending Changes - Ideas for Survival

    • Universal Influenza Immunization Program and OPA Store Insurance

    • Health Canada Drug Shortages Updates – Week of September 7, 2020

    • Important Safety Information on ESBRIET (pirfenidone) – Risk of Drug-Induced Liver Injury
    • Recall of Certain Hand Sanitizers That May Pose Health Risks
    • Importation of US Clinical Trial-Labelled Remdesivir for Injection Due to Shortage of Canadian-Labelled Remdesivir - Gilead Sciences Canada, Inc.

  • News for the Week of September 8, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • ICYMI: Changes to the 2020-21 Universal Influenza Immunization Program (UIIP)
    • OPA’s Universal Influenza Immunization Program (UIIP) 2020-21 Frequently Asked Questions
    • Guidance for Influenza Vaccine Delivery in the Presence of COVID-19
    • OPA Submission to Amendments to Regulations 682 and 683 under the Laboratory Specimen Collection Centre Licensing Act, 1990
    • OPA Submission to Proposed Regulations under the Connecting People to Home and Community Care Act, 2020
    • Controlled Drugs and Substances Act Section 56 Exemption Extension to September 30, 2021
    • COVID-19 Resources and Tools
    • Inaugural meeting of OPA's Diversity Task Force
    • External Research Initiatives and Resources

    • Ask Customer Experience Administration Team
    • Order PPE Faster, Easier and Save More!
    • Ripley's Aquarium Offers Discount for OPA Members
    • Prepare Your Store/Workplace for the Fall Season, Order Hand Sanitizers Today

    • Landmark Changes in Asthma Management
    • A Practical Approach to Laboratory Abnormalities
    • Pharmacist Health Coaching – Cardiovascular Program Training Course

    • Business Expense Disability Insurance

    • Health Canada Drug Shortages Updates, August 12, 2020
    • Health Canada Drug Shortages Updates, August 18, 2020
    • Health Canada Drug Shortages Updates – Week of August 24, 2020

    • DDD Notice 20129 Posted August 5, 2020 Executive Officer Notice: Funding of Allerject® (Epinephrine Auto-Injector) Through the Allergen Program
    • DDD Notice No. 20130 Posted August 5, 2020 Prescription Forgery Alert
    • DDD Notice No. 20132 Posted August 14, 2020: Notice from the EO – Monitored Drugs List (MDL) Update Effective: August 14, 2020
    • DDD Notice No. 20133 Posted August 21, 2020: ODB Formulary Edition No. 43, Summary of Changes – August 28, 2020
    • DDD Notice No. 20134 Posted August 24, 2020: Executive Officer Notice and Frequently Asked Questions: Funding of Riximyo and Ruxience Under the Ontario Drug Benefit Program
    • DDD Notice No. 20136 Posted August 28, 2020 Prescription Forgery Alert
    • DDD Notice No. 20137 Posted August 28, 2020 Prescription Forgery Alert
    • DDD Notice No. 20138 Posted September 3, 2020 Prescription Forgery Alert
    • DDD Notice No. 20139 Posted September 3, 2020 Prescription Forgery Alert
    • DDD Notice No. 20140 Posted September 4, 2020 Health Network System (HNS) and Narcotics Monitoring System (NMS) Outage Notification to Ontario Drug Programs Agencies

    • Recall of Certain Hand Sanitizers that Contain Technical-grade Ethanol
    • Prescription Cough and Cold Products Containing Opioids and the Risk of Opioid Use Disorder in Children and Adolescents (< 18 years of age)
    • Health Product InfoWatch, August 2020
    • UPDATE – Pharmascience Inc. Recalls One Lot of PMS-Ranitidine as a Precaution
    • Hand Sanitizers in Non-Traditional Packaging, Including Squeeze Pouches Commonly Used for Food and Beverages
    • Recall of Certain Hand Sanitizers That May Pose Health Risks

  • News for the Week of August 4, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Preparing for Stage 3 and Flu Season
    • Encourage Your Patients to Download the COVID Alert App to Prevent Community Spread of COVID-19
    • COVID-19 Resources and Tools
    • External Research Initiatives and Resources

    • Ask the Practice Support Network

    • Complimentary Live Webinar: Landmark Changes in Asthma Management

    • Surviving a Critical Illness
    • Professional Liability Insurance Claims Reporting

    • Health Canada Drug Shortages Updates, July 29, 2020

    • DDD Notice No. 20128 posted August 4, 2020 Prescription Forgery Alert
    • DDD Notice No. 20127 posted August 4, 2020 Prescription Forgery Alert
    • DDD Notice No. 20124 posted July 30, 2020 Executive Officer Notice: Inspections Return to Work

    • Health Product InfoWatch, July 2020
    • Recall of Certain Hand Sanitizers That May Pose Health Risks
    • Non-Prescription Pain Relief Products Containing Codeine Are Not Recommended for Use in People Under 18 Years of Age

  • News for the Week of July 28, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • OPA Submission - Regulatory Amendments to Ontario Regulation 202/94 (General) made under the Pharmacy Act, 1991
    • OPA Submission – Proposed Regulatory Amendments to Ontario Regulation 329/04 under the Personal Health Information Protection Act, 2004
    • Pharmacy Audits by Third-party Payors on ODB Co-payments Submitted During the Ministry's COVID-19 Supply Limit Recommendation
    • Reminder: Express Scripts Canada (ESC) Claims Submissions over $9,999.99

    • Ask the Customer Experience and Administration Team

    • The MASTER Plan for Diabetes Continuing Education Program
    • Mastering Injections in Pediatrics
    • Providing LGBTQ+ Inclusive Care at Your Pharmacy

    • Hospital Coverage Is Provided by Your OPA Secure Health Plan
    • Pharmacy Risk Prevention Tips

    • DDD Notice No. 20123 Posted July 28, 2020 Prescription Forgery Alert
    • DDD Notice No. 20121 Posted July 24, 2020: Notice from the Executive Officer – Monitored Drugs List (MDL) Update Effective: July 24, 2020
    • DDD Notice No. 20120 Posted July 24, 2020: ODB Formulary Edition No. 43, Summary of Changes – July 31, 2020
    • DDD Notice No. 20119 Posted July 24, 2020 Prescription Forgery Alert

    • Status of Ranitidine Drugs in Canada
    • Remdesivir Authorized with Conditions for the Treatment of Patients in Canada with Severe COVID-19 Symptoms

  • News for the Week of July 21, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Reminder: Public Consultation on the Regulatory Amendments for Expansion of Scope Closing July 27, 2020
    • Non-Insured Health Benefits (NIHB) Program Providers Update
    • Concerns, Beliefs and Attitudes of Pharmacists About Cannabis Use Survey
    • New Episode of Pharmacists' Matters Available Now

    • Ask the Practice Support Network
    • Reduced Pricing on Hand Sanitizer for Pharmacy Professionals

    • An Update on Direct Oral Anticoagulation
    • Managing Your Pharmacy: The Business Essentials
    • Board Certified Geriatric Pharmacist (BCGP) Preparation Course – Medication Therapy Management for Older Adults

    • Why Students Need Life Insurance
    • Dependent Children’s Insurance

    • Importation of PTU™ (Propylthiouracil) 50 mg due to Shortage of Canadian Labelled Propylthiouracil 50 mg Products

    • DDD Notice No. 20117 Posted July 21, 2020 Prescription Forgery Alert
    • DDD Notice No. 20116 Posted July 15, 2020 Prescription Forgery Alert

    • Three Lots of Antidiuretic DDAVP Spray Recalled Because of Potential Overdose Risk
    • Health Canada Important Safety Information on Methadone Treatment of Opioid Dependence and Potential Risk of Lack of Effect when Switching between Different Products

  • News for the Week of July 14, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • ODPRN Ontario Prescription Opioid Tool: Quarterly Update – COVID-19 Insights
    • Update from the Canadian Red Cross
    • TELUS Health 2020 Health Drug Data Trends and National Benchmarks Report
    • CPhA COVID-19 Resource: In-pharmacy Poster for Encouraging Use of Masks

    • Ask the Customer Experience and Administration Team

    • How to Add Value to the Pharmacy Business as a Pharmacy Technician
    • Applying NAPRA's Non-Sterile Compounding Standards Into Practice
    • Mastering Injections in Pediatrics

    • COSECO Insurance Company unites with Co-operators General Insurance Company
    • Do I Need Life insurance?

    • DDD Notice No. 20113 posted July 13, 2020 Prescription Forgery Alert
    • DDD Notice No. 20112 posted July 9, 2020 Prescription Forgery Alert

  • News for the Week of July 7, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • ICYMI: OPA Board Elections
    • FINAL REMINDER: UIIP Application Deadline is Friday, July 10
    • Updated: OPA’s COVID-19 Insurance Exceptions Tool
    • NIHB Program Launches New Claims Processing System and Services via Express Scripts Canada

    • Ask the Practice Support Network
    • Summer Benefit Reminders for OPA Members

    • Pandemic Tips: Return to Work Guidance
    • How Can Pharmacists Optimize the Care of Patients with Heart Failure?
    • The Right Dose: The Positives and Negatives of COVID-19 Testing in Pharmacies

    • Get Your 15% Reduced Driving Refund
    • Are You Insured Through Your Employer’s Group Plan for Long-Term Disability (LTD)?

    • Use of the Drug Picato May Increase the Risk of Skin Cancer
    • Recall of Certain Hand Sanitizers That May Pose Health Risks
    • Certain Vials of Fertility Drug Cetrotide Recalled Because of Potential Contamination
    • Counterfeit Respirators

Back to top